SCHEMBL7791499

SCHEMBL7791499

CCOC(=O)C(CC(=O)c1ccc(Cl)cc1OC)(NC=O)C(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.41
LMNA P02545 1/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
FBP1 P09467 1/20 0.36
ABCB11 O95342 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
HTR2A P28223 1/20 0.36
PMP22 Q01453 1/20 0.36
PPARA Q07869 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 4/20 0.36
HTT P42858 1/20 0.36
HCRTR1 O43613 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7797652 0.88 L3MBTL1 (0.46) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL7797647 0.87 ALDH1A1 (0.46) LMNAALDH1A1KMT2AMEN1POLB
SCHEMBL7797559 0.87 ALDH1A1 (0.38) CNR2LMNAALDH1A1KMT2AMEN1
SCHEMBL7797580 0.85 ERCC5 (0.43) LMNAALDH1A1KMT2AMEN1ABCB11
SCHEMBL7791495 0.84 NPC1 (0.46) LMNAALDH1A1KMT2AMEN1POLB
SCHEMBL9178311 0.83 L3MBTL1 (0.46) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL8656066 0.82 ALDH1A1 (0.46) LMNAALDH1A1KMT2AMEN1TSHR
SCHEMBL7802020 0.81 MEN1 (0.46) LMNAALDH1A1KMT2AMEN1TSHR
SCHEMBL8654757 0.80 ERCC5 (0.43) LMNAALDH1A1KMT2AMEN1ABCB11
SCHEMBL7799547 0.80 SMN1; SMN2 (0.45) LMNAALDH1A1KMT2AMEN1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed
EP-0662948-B1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN SPA (IT) 1998-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT CNR2 742/4885LMNA 3836/4885FLT1 4108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.